Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/31/2005CA2539066A1 Delivering genetic material to a stimulation site
03/31/2005CA2539065A1 Coumpounds for neutralising the effects of secreted pla2 iia
03/31/2005CA2538999A1 Regulation of cardiac contractility and heart failure propensity
03/31/2005CA2538840A1 Dna vaccine compositions and methods of use
03/31/2005CA2538729A1 Compound and method for treating androgen-independent prostate cancer
03/31/2005CA2538252A1 4'-thionucleosides and oligomeric compounds
03/31/2005CA2537085A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
03/31/2005CA2536526A1 Methods, compositions, and kits for the concentration and detection of microorganisms
03/31/2005CA2535866A1 Methods and compositions for enhanced plant cell transformation
03/31/2005CA2526834A1 Recombinant influenza vectors with a polii promoter and ribozymes
03/31/2005CA2523657A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
03/30/2005EP1518937A1 Increasing the concentration of a nucleic acid molecule
03/30/2005EP1518933A1 Vectors and methods for gene transfer to cells
03/30/2005EP1518932A1 Modified vaccinia virus Ankara (MVA) mutant and use thereof
03/30/2005EP1518931A1 Use of P-selectin glycoprotein ligand-1 (PSGL-1) and fragments thereof for the inhibition of thrombosis
03/30/2005EP1518930A2 Methods and compositions for inhibiting neoplastic cell growth
03/30/2005EP1518929A1 Novel genes
03/30/2005EP1518928A1 Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method
03/30/2005EP1518927A2 Optimization of immunomodulatory properties of genetic vaccines
03/30/2005EP1518926A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT
03/30/2005EP1518864A2 Antibody against rhesus D
03/30/2005EP1518558A2 Vaccine against infection with Actinobacillus pleuropneumoniae comprising purified ApxIV toxin
03/30/2005EP1517998A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
03/30/2005EP1517992A2 Retrons for gene targeting
03/30/2005EP1517991A2 Method of transforming soybean
03/30/2005EP1517990A1 Isolation of nucleic acids using a polycationic polymer as precipitation agent
03/30/2005EP1517989A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
03/30/2005EP1517986A2 Bacterial cell digestion
03/30/2005EP1517923A2 Compositions and methods for inhibiting microbial adhesion
03/30/2005EP1517921A2 Immunoglobulin single variable antigen-binding domains and dual-specific constructs thereof
03/30/2005EP1517919A2 Marked peptides having affinity for a phospholipid and uses
03/30/2005EP1517918A2 Peptides having affinity for a phospholipid and uses
03/30/2005EP1517917A2 Human erg2 potassium channel
03/30/2005EP1517916A2 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods
03/30/2005EP1517913A2 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
03/30/2005EP1517912A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
03/30/2005EP1517701A2 Lewis y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517699A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
03/30/2005EP1517606A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
03/30/2005EP1517605A2 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof
03/30/2005EP1517604A2 No-apical meristem proteins, polynucleotides and methods of use for same
03/30/2005EP1487976A4 Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides
03/30/2005EP1448777A4 Method for genetic transformation of woody trees
03/30/2005EP1440311A4 Affinity-shifted probes for quantifying analyte polynucleotides
03/30/2005EP1429648A4 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER
03/30/2005EP1407047A4 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION
03/30/2005EP1392341B1 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof
03/30/2005EP1390501A4 Determination of a genetic predisposition for behavioural disorders
03/30/2005EP1357790A4 Method for identifying genes involved in cell proliferation
03/30/2005EP1356063B1 Expression of multiple proteins in transgenic plants
03/30/2005EP1311697B1 Constitutive promoter from arabidopsis
03/30/2005EP1248859B1 Method for synthesising and immobilising nucleic acids on a silanized solid support
03/30/2005EP1229781A4 Seed trait genes
03/30/2005EP1229780A4 Yield-related genes
03/30/2005EP1224298B1 Fibrinolytically active polypeptide
03/30/2005EP1218076A4 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
03/30/2005EP1216299B1 Gene transfer in human lymphocytes using retroviral scfv cell targeting vectors
03/30/2005EP1203088B1 Conditionally controlled, attenuated hiv vaccine
03/30/2005EP1200105B1 Modified factor viii
03/30/2005EP1187925B1 Pectate lyase fusion for expression and secretion of polypeptides
03/30/2005EP1183361B1 Gene therapy of pulmonary disease
03/30/2005EP1124570A4 Novel neuropilin/growth factor binding and uses thereof
03/30/2005EP1080208B1 Dsrna-mediated regulation of gene expression in plants
03/30/2005EP1080187A4 Modification of cereal grain hardness via expression of puroindoline proteins
03/30/2005EP1064394B8 Method for ballistic transformation of caenorhabditis elegans
03/30/2005EP1047777B1 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
03/30/2005EP1025241B1 Multiply-substituted protease variants
03/30/2005EP1019532B1 Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae
03/30/2005EP1001978B1 Angiotensin derivatives
03/30/2005EP0928290B1 Oligoribonucleotides and ribonucleases for cleaving rna
03/30/2005EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof
03/30/2005CN1602427A Inhibition of tristetraproline for protection of the heart from cardiac injuries
03/30/2005CN1602425A Therapeutic and diagnostic uses of antibody specificity profiles
03/30/2005CN1602362A Methods for determining transcriptional activity
03/30/2005CN1602361A Hybridization portion control oligonucleotide and its uses
03/30/2005CN1602360A Methods of increasing endogenous erythropoietin (EPO)
03/30/2005CN1602359A Methods of preparing a targeting vector and uses thereof
03/30/2005CN1602358A Recombinant fusion proteins and the trimers thereof
03/30/2005CN1602357A Novel phytases and method for producing these phytases
03/30/2005CN1602356A Transgenic organism expressing fungal MRP-like ABC transporters
03/30/2005CN1602355A Human fibroblast growth factor-related compositions
03/30/2005CN1602354A Human coagulation factor VII polypeptides
03/30/2005CN1602352A Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
03/30/2005CN1602351A Islet cells from human embryonic stem cells
03/30/2005CN1602317A Angiopoietin-2 specific binding agents
03/30/2005CN1602316A Flavivirus NS1 subunit vaccine
03/30/2005CN1602315A Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
03/30/2005CN1602207A Methods for inhibiting ocular processes
03/30/2005CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/30/2005CN1602201A Peptides and related compounds having thrombopoietic activity
03/30/2005CN1601383A Method for fabricating a carbon nanotube chip and a biochip using the self-assembly of super molecules and staining of metal compound
03/30/2005CN1600863A Plasmid on operating platform for knocking out gene of plant in cereal, construction method and application
03/30/2005CN1600862A Clone and application of alcohol fermentation gene of unit cell fungus through motion ferment
03/30/2005CN1600861A Protein coded sequence of binding factor in ethane response element of cotton
03/30/2005CN1600860A Meiosis gene of paddy, coding protein and application
03/30/2005CN1600859A Meiosis gene of paddy, coded protein and application
03/30/2005CN1600858A SiRNA for restraining melanin, preparation method and application
03/30/2005CN1600857A RIP5 gene and usage
03/30/2005CN1600856A Method for constructing hybridoma cell line of heterogeneity of seereting human monoclonal antibody for anti hepatitis B
1 ... 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 ... 4023